Ovarian cancer vaccine (MSKCC)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOvarian cancer vaccine (MSKCC)
Drug Alias Name卵巢癌疫苗 - MabVax/MSKCCPolyvalent vaccine-KLH conjugateNSC-748933MV-Ovar
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A